Home › Sun Pharma Declines as Regulatory Issue Puts Pressure on Profit
 

Keywords :   


Sun Pharma Declines as Regulatory Issue Puts Pressure on Profit

2015-02-16 08:49:03| Chemicals - Topix.net

Sun Pharmaceutical Industries Ltd., India's largest drugmaker, fell in Mumbai trading as quarterly profit came under pressure from efforts to address regulatory issues at one of its factories. Sun Pharma fell as much as 3.5 percent to 907.30 rupees in Mumbai today before trading at 915.25 rupees at 9:34 a.m. local time, the biggest decliner on the benchmark S&P BSE Sensex Index.

Tags: issue sun pressure profit

Category:Chemicals

Latest from this category

All news
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
31.10Nippon Paint Holdings to Acquire AOC from Lone Star Funds
31.10RPM Acquires TMP Convert
31.10AkzoNobels Largest European Solar Energy Plant Goes Live in Poland
30.10BASF Groups EBITDA Before Special Items Up from Q3 2023
30.10Axalta Reports Record Net Sales in 3Q 2024
30.10Zack Hays Joins Orion S.A. as Marketing Manager
30.10UK Linseed Paint Maker Launches US Venture
Chemicals »
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Global BEEF Series: Leveling the playing field on quality beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
More »